Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Zim Laboratories LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:541400NSE Symbol: ZIMLABP/E(TTM):33.14
ISIN Demat:INE518E01015Div & Yield %:0EPS(TTM):3.44
Book Value(Rs):47.6042974Market Cap ( Cr.):555.47Face Value(Rs):10
    Change Company 
( In Cr)
 Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
INCOME :      
Sales Turnover 396.53329.49303.63274.32331.72273.36
Excise Duty0.000.000.000.000.001.47
Net Sales396.53329.49303.63274.32331.72271.89
Other Income 6.434.512.454.662.059.29
Stock Adjustments -16.469.671.116.400.120.90
Total Income386.50343.67307.19285.38333.89282.08
EXPENDITURE :      
Raw Materials 182.37170.02159.74149.54159.63141.79
Power & Fuel Cost11.099.147.047.477.195.75
Employee Cost 46.4738.6334.4834.5848.1440.80
Other Manufacturing Expenses 27.3023.7619.0222.376.664.68
Selling and Administration Expenses 55.6954.4443.7040.9663.2642.14
Miscellaneous Expenses 5.955.249.126.014.543.67
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure328.87301.23273.11260.94289.42238.84
Operating Profit57.6342.4434.0824.4344.4743.24
Interest 5.588.3110.8912.6510.599.34
Gross Profit52.0534.1323.1911.7833.8833.90
Depreciation16.1314.8414.6113.2711.149.79
Profit Before Tax35.9219.298.58-1.4922.7424.11
Tax6.283.400.02-0.124.90-1.26
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax4.632.882.95-3.101.827.08
Reported Net Profit25.0113.015.621.7416.0118.29
Extraordinary Items 0.000.00-3.39-0.01-0.294.06
Adjusted Net Profit25.0113.019.011.7516.3014.23
Adjst. below Net Profit 0.000.000.000.490.000.00
P & L Balance brought forward111.8198.7693.5292.5477.9260.72
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 0.46-0.050.391.241.391.09
P & L Balance carried down136.36111.8198.7693.5292.5477.92
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %0.000.000.000.005.0010.00
Earnings Per Share-Unit Curr5.138.013.461.089.9322.69
Earnings Per Share(Adj)-Unit Curr5.132.671.150.363.31NA
Book Value-Unit Curr39.85104.7396.6993.7993.81168.70